USS Investment Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.3M | Buy |
970,841
+22,335
| +2% | +$595K | 0.11% | 101 |
|
|
2025
Q4 | $23.6M | Hold |
948,506
| – | – | 0.11% | 110 |
|
|
2025
Q3 | $24.2M | Hold |
948,506
| – | – | 0.11% | 107 |
|
|
2025
Q2 | $23M | Buy |
948,506
+14,392
| +2% | +$336K | 0.14% | 96 |
|
|
2025
Q1 | $23.7M | Sell |
934,114
-1,024,400
| -52% | -$26.8M | 0.17% | 88 |
|
|
2024
Q4 | $52M | Sell |
1,958,514
-65,118
| -3% | -$1.77M | 0.36% | 50 |
|
|
2024
Q3 | $58.6M | Hold |
2,023,632
| – | – | 0.43% | 40 |
|
|
2024
Q2 | $56.6M | Buy |
2,023,632
+257,724
| +15% | +$7.1M | 0.45% | 35 |
|
|
2024
Q1 | $49M | Buy |
1,765,908
+54,769
| +3% | +$1.52M | 0.4% | 41 |
|
|
2023
Q4 | $49.3M | Buy |
1,711,139
+56,920
| +3% | +$1.72M | 0.44% | 37 |
|
|
2023
Q3 | $54.9M | Buy |
1,654,219
+43,949
| +3% | +$1.55M | 0.59% | 32 |
|
|
2023
Q2 | $59.1M | Buy |
1,610,270
+154,861
| +11% | +$6.03M | 0.7% | 25 |
|
|
2023
Q1 | $59.4M | Buy |
1,455,409
+33,845
| +2% | +$1.46M | 0.81% | 23 |
|
|
2022
Q4 | $72.9M | Sell |
1,421,564
-142,256
| -9% | -$6.82M | 1.02% | 11 |
|
|
2022
Q3 | $68.6M | Sell |
1,563,820
-415,236
| -21% | -$20.2M | 1% | 10 |
|
|
2022
Q2 | $104M | Sell |
1,979,056
-218,055
| -10% | -$11.1M | 1.04% | 11 |
|
|
2022
Q1 | $114M | Buy |
2,197,111
+71,693
| +3% | +$3.72M | 0.93% | 12 |
|
|
2021
Q4 | $125M | Sell |
2,125,418
-3,300
| -0.2% | -$164K | 0.95% | 12 |
|
|
2021
Q3 | $91.5M | Buy |
2,128,718
+218,977
| +11% | +$9.7M | 0.77% | 17 |
|
|
2021
Q2 | $74.8M | Buy |
1,909,741
+5,100
| +0.3% | +$198K | 0.59% | 47 |
|
|
2021
Q1 | $69M | Hold |
1,904,641
| – | – | 0.6% | 44 |
|
|
2020
Q4 | $70.1M | Sell |
1,904,641
-157,342
| -8% | -$5.77M | 0.64% | 40 |
|
|
2020
Q3 | $71.8M | Hold |
2,061,983
| – | – | 0.69% | 36 |
|
|
2020
Q2 | $64M | Buy |
2,061,983
+649,681
| +46% | +$22.1M | 0.67% | 41 |
|
|
2020
Q1 | $43.7M | Buy |
1,412,302
+983,429
| +229% | +$33.5M | 0.6% | 51 |
|
|
2019
Q4 | $15.9M | Buy |
428,873
+175,281
| +69% | +$6.24M | 0.16% | 95 |
|
|
2019
Q3 | $8.64M | Hold |
253,592
| – | – | 0.09% | 118 |
|
|
2019
Q2 | $10.4M | Sell |
253,592
-11,489
| -4% | -$456K | 0.11% | 110 |
|
|
2019
Q1 | $10.7M | Hold |
265,081
| – | – | 0.12% | 93 |
|
|
2018
Q4 | $11M | Sell |
265,081
-25,507
| -9% | -$1.06M | 0.14% | 81 |
|
|
2018
Q3 | $12.2M | Hold |
290,588
| – | – | 0.12% | 79 |
|
|
2018
Q2 | $10M | Hold |
290,588
| – | – | 0.11% | 87 |
|
|
2018
Q1 | $10.1M | Buy |
290,588
+95,282
| +49% | +$3.28M | 0.11% | 94 |
|
|
2017
Q4 | $6.72M | Buy |
+195,306
| New | +$6.66M | 0.08% | 113 |
|
|
2017
Q2 | – | Sell |
-186,980
| Closed | -$6.07M | – | 155 |
|
|
2017
Q1 | $6.07M | Buy |
186,980
+16,759
| +10% | +$528K | 0.08% | 106 |
|
|
2016
Q4 | $5.25M | Hold |
170,221
| – | – | 0.08% | 126 |
|
|
2016
Q3 | $5.47M | Buy |
+170,221
| New | +$5.69M | 0.08% | 127 |
|
|
2016
Q1 | – | Sell |
-2,909,631
| Closed | -$89.1M | – | 144 |
|
|
2015
Q4 | $89.1M | Hold |
2,909,631
| – | – | 1.47% | 27 |
|
|
2015
Q3 | $86.7M | Hold |
2,909,631
| – | – | 1.54% | 25 |
|
|
2015
Q2 | $92.6M | Hold |
2,909,631
| – | – | 1.47% | 29 |
|
|
2015
Q1 | $96M | Hold |
2,909,631
| – | – | 1.57% | 25 |
|
|
2014
Q4 | $86M | Hold |
2,909,631
| – | – | 1.41% | 31 |
|
|
2014
Q3 | $81.6M | Sell |
2,909,631
-252,960
| -8% | -$7.1M | 1.43% | 30 |
|
|
2014
Q2 | $89.1M | Hold |
3,162,591
| – | – | 1.53% | 27 |
|
|
2014
Q1 | $96.4M | Hold |
3,162,591
| – | – | 1.74% | 16 |
|
|
2013
Q4 | $91.6M | Hold |
3,162,591
| – | – | 1.76% | 17 |
|
|
2013
Q3 | $86.2M | Hold |
3,162,591
| – | – | 1.61% | 17 |
|
|
2013
Q2 | $84M | Buy |
+3,162,591
| New | +$87.4M | 1.79% | 12 |
|
Other funds holding PFE
VCM
VPM
USS Investment Management's PFE Position: Q1 2026 in Review
USS Investment Management increased its Pfizer (PFE) stake by 2.4% in Q1 2026, buying an estimated $595K and bringing the position to 970,841 shares worth $27.3M. The position accounts for 0.11% of the portfolio, ranked #101.
USS Investment Management first reported a position in PFE in Q2 2013 and has held it in 48 quarters since. The position peaked at $125M in Q4 2021. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- USS Investment Management held 970,841 shares of Pfizer worth $27.3M as of Q1 2026.
- USS Investment Management bought 22,335 Pfizer shares in Q1 2026, an estimated $595K.
- Pfizer made up 0.11% of USS Investment Management's portfolio in Q1 2026, its #101 holding.
- USS Investment Management first reported a position in Pfizer in Q2 2013 and has held it in 48 quarters since.
- USS Investment Management's Pfizer position peaked at $125M in Q4 2021.
- 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on USS Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.